Research

Zacks Small Cap Research – UHAL: Reports 3Q FY2025 Results: Demand for self-moving equipment rentals increases YOY for the 3rd consecutive quarter after seven quarters of single-digit declines. Self-Storage continues to deliver top-line growth. Record amount of self-storage rentable sq. ft. added in last 12 months. – Go Health Pro

by
Zacks Small Cap Research – UHAL: Reports 3Q FY2025 Results: Demand for self-moving equipment rentals increases YOY for the 3rd consecutive quarter after seven quarters of single-digit declines. Self-Storage continues to deliver top-line growth. Record amount of self-storage rentable sq. ft. added in last 12 months. – Go Health Pro

By Steven Ralston, CFA NYSE:UHAL READ THE FULL UHAL RESEARCH REPORT U-Haul Holding Company (NYSE:UHAL) reported financial results for 3Q FY2025 on February 5th. Total revenues increased 3.7% to approximately $1.39 billion, primarily due to stronger revenue growth of 4.6% in the self-moving equipment rental business, along with a 7.9% increase in theself-storage segment. In … Read more

Zacks Small Cap Research – TELO Improves Balance Sheet – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. … Read more

Zacks Small Cap Research – PLX: Revisiting the Thesis – Go Health Pro

by
Zacks Small Cap Research – PLX: Revisiting the Thesis – Go Health Pro

By John Vandermosten, CFA NYSE:PLX READ THE FULL PLX RESEARCH REPORT Reasons To Own / A Compelling Idea for 2025 Protalix Biotherapeutics, Inc. (NYSE:PLX) finds itself in an enviable position as we begin 2025. The company has two approved products generating revenues and a pipeline with multiple candidates in development. Its products are produced and … Read more

OpenAI launches ‘deep research’ AI agent for ChatGPT – Go Health Pro

by
OpenAI launches ‘deep research’ AI agent for ChatGPT – Go Health Pro

On the heels of its o3 mini release, OpenAI announced a new ChatGPT agent for handling in-depth research. Appropriately, it’s called “deep research.” Using a yet-to-be-released version of OpenAI’s reasoning model o3, deep research “conducts multi-step research on the internet for complex tasks,” said the announcement. Deep research on ChatGPT essentially functions as your very … Read more

Zacks Small Cap Research – AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier – Go Health Pro

by
Zacks Small Cap Research – AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier – Go Health Pro

By M. Marin NASDAQ:AEMD Aethlon Medical (NASDAQ:AEMD) announced that the first patient in its Australian safety, feasibility and dose-finding clinical trial has been treated with the Hemopurifier. The trial is designed for patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment. In other words, the trial is evaluating the Hemopurifier … Read more